• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经年龄与代谢功能障碍相关脂肪性肝病风险的关系:一项 14 年的队列研究。

Age at menopause and risk of metabolic dysfunction-associated fatty liver disease: A 14-year cohort study.

机构信息

Department of Family Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1, Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.

Department of Biostatistics and Computing, Yonsei University, Seoul 03722, Korea.

出版信息

Dig Liver Dis. 2024 Nov;56(11):1880-1886. doi: 10.1016/j.dld.2024.05.003. Epub 2024 May 18.

DOI:10.1016/j.dld.2024.05.003
PMID:38763798
Abstract

BACKGROUNDS & AIMS: Menopause, characterized by a sudden decline in estrogen levels, has significant effects on women's health, especially when it occurs early. This study aimed to investigate the associations between menopausal age and incidence of metabolic dysfunction-associated fatty liver disease (MAFLD) using a large cohort and a long-term follow-up.

METHODS

Menopausal age was categorized into four groups (G1-4 [<40, 40-44, 45-49, and ≥50 years, respectively]). Cox proportional hazards regression analysis was used to assess the risk of developing MAFLD during the follow-up period according to the menopausal age categories.

RESULTS

A total of 1,888 participants were included in the final analysis and followed for a median period of 12.3 years. The unadjusted hazard ratios (95 % CIs) for the incidence of new-onset MAFLD were 1.11 (0.93-1.32), 1.15 (0.90-1.47), and 1.52 (1.12-2.07) in G3, G2, and G1, respectively, compared with that in G4. After adjusting for confounders, the hazard ratio (95 % CIs) for the incidence of new-onset MAFLD was 1.40 (1.00-1.95) in G1 compared with that in G4.

CONCLUSION

The risk of developing MAFLD was higher in women with premature menopause (<40 years) than in those with menopause aged ≥50 years.

摘要

背景与目的

绝经是指雌激素水平突然下降,对女性健康有重大影响,尤其是绝经发生较早时。本研究旨在使用大型队列和长期随访来探讨绝经年龄与代谢相关脂肪性肝病(MAFLD)发病之间的关系。

方法

绝经年龄分为四组(G1-4 [<40、40-44、45-49 和≥50 岁])。使用 Cox 比例风险回归分析根据绝经年龄组评估随访期间发生 MAFLD 的风险。

结果

共有 1888 名参与者被纳入最终分析,并随访了中位数为 12.3 年的时间。未调整的新发病例 MAFLD 的风险比(95%CI)在 G3、G2 和 G1 组分别为 1.11(0.93-1.32)、1.15(0.90-1.47)和 1.52(1.12-2.07),与 G4 组相比。调整混杂因素后,G1 组新发 MAFLD 的风险比(95%CI)为 1.40(1.00-1.95),与 G4 组相比。

结论

与绝经年龄≥50 岁的女性相比,绝经年龄过早(<40 岁)的女性发生 MAFLD 的风险更高。

相似文献

1
Age at menopause and risk of metabolic dysfunction-associated fatty liver disease: A 14-year cohort study.绝经年龄与代谢功能障碍相关脂肪性肝病风险的关系:一项 14 年的队列研究。
Dig Liver Dis. 2024 Nov;56(11):1880-1886. doi: 10.1016/j.dld.2024.05.003. Epub 2024 May 18.
2
The Role of Metabolic Dysfunction-Associated Fatty Liver Disease in Developing Chronic Kidney Disease: Longitudinal Cohort Study.代谢相关脂肪性肝病在慢性肾脏病进展中的作用:纵向队列研究。
JMIR Public Health Surveill. 2023 May 4;9:e45050. doi: 10.2196/45050.
3
Association between the triglyceride to high density lipoprotein cholesterol ratio and the incidence of metabolic dysfunction-associated fatty liver disease: a retrospective cohort study.甘油三酯与高密度脂蛋白胆固醇比值与代谢相关脂肪性肝病发病的相关性:一项回顾性队列研究。
BMC Gastroenterol. 2024 Nov 1;24(1):389. doi: 10.1186/s12876-024-03471-w.
4
Healthy Lifestyle and the Risk of Metabolic Dysfunction-Associated Fatty Liver Disease: A Large Prospective Cohort Study.健康生活方式与代谢相关脂肪性肝病风险:一项大型前瞻性队列研究。
Diabetes Metab J. 2024 Sep;48(5):971-982. doi: 10.4093/dmj.2023.0133. Epub 2024 Mar 19.
5
Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China.非酒精性脂肪性肝病与糖尿病、慢性肾脏病和心血管疾病的关联:一项在中国进行的4.6年队列研究
J Clin Endocrinol Metab. 2022 Jan 1;107(1):88-97. doi: 10.1210/clinem/dgab641.
6
The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis.代谢功能障碍相关脂肪性肝病的进展和消退与亚临床动脉粥样硬化的发生有关:一项前瞻性分析。
Metabolism. 2021 Jul;120:154779. doi: 10.1016/j.metabol.2021.154779. Epub 2021 Apr 23.
7
Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.代谢相关脂肪性肝病与中国成年人死亡风险的前瞻性队列研究。
J Clin Endocrinol Metab. 2022 Jan 18;107(2):e745-e755. doi: 10.1210/clinem/dgab644.
8
Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study.代谢相关脂肪性肝病与慢性肾脏病发病风险的关系:一项全国性队列研究。
Diabetes Metab. 2022 Jul;48(4):101344. doi: 10.1016/j.diabet.2022.101344. Epub 2022 Mar 25.
9
Comparison of all-cause mortality associated with non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease in Taiwan MJ cohort.台湾 MJ 队列中非酒精性脂肪性肝病和代谢相关脂肪性肝病与全因死亡率的比较。
Epidemiol Health. 2024;46:e2024024. doi: 10.4178/epih.e2024024. Epub 2024 Jan 21.
10
Waistline to thigh circumference ratio as a predictor of MAFLD: a health care worker study with 2-year follow-up.腰围与大腿围之比作为MAFLD的预测指标:一项为期2年随访的医护人员研究
BMC Gastroenterol. 2024 Apr 24;24(1):144. doi: 10.1186/s12876-024-03229-4.

引用本文的文献

1
Lipid Hormones at the Intersection of Metabolic Imbalances and Endocrine Disorders.代谢失衡与内分泌紊乱交叉点上的脂质激素
Curr Issues Mol Biol. 2025 Jul 18;47(7):565. doi: 10.3390/cimb47070565.
2
The Ovary-Liver Axis: Molecular Science and Epidemiology.卵巢-肝脏轴:分子科学与流行病学
Int J Mol Sci. 2025 Jul 2;26(13):6382. doi: 10.3390/ijms26136382.
3
Health disorders in menopausal women: microbiome alterations, associated problems, and possible treatments.更年期女性的健康问题:微生物群改变、相关问题及可能的治疗方法。
Biomed Eng Online. 2025 Jul 7;24(1):84. doi: 10.1186/s12938-025-01415-3.
4
Menopause and gastrointestinal health and disease.更年期与胃肠道健康及疾病
Nat Rev Gastroenterol Hepatol. 2025 May 23. doi: 10.1038/s41575-025-01075-7.
5
MASLD: Prevalence, Mechanisms, and Sex-Based Therapies in Postmenopausal Women.绝经后女性的代谢功能障碍相关脂肪性肝病:患病率、发病机制及基于性别的治疗方法
Biomedicines. 2025 Apr 2;13(4):855. doi: 10.3390/biomedicines13040855.
6
Editorial: Cardiometabolic diseases in postmenopausal women.社论:绝经后女性的心血管代谢疾病
Front Endocrinol (Lausanne). 2024 Nov 7;15:1514913. doi: 10.3389/fendo.2024.1514913. eCollection 2024.